🇺🇸 FDA

Company profile · Sponsor

Ono

Ono Pharmaceutical Co.,

CA7C779 · NMPA pharma CN
Pipeline
4
Drugs
0
Patents
0

Quick answer

Ono (CA7C779) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CA7C779
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (4)

Search pipeline →

  1. Nivolumab

    Ono

    Gastric Cancer

    phase 3 small molecule completed

    1 trial

  2. Placebo

    Ono

    Chronic Sinusitis

    phase 3 small molecule completed

    1 trial

  3. ONO-4578

    Ono

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

  4. ONO-4578

    Ono

    Metastatic Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Ono?

Ono (CA7C779) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Ono sponsor?

We track 4 ClinicalTrials.gov-linked programs for Ono, including Nivolumab and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Ono company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.